X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Divis Laboratories with J.B.Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs J.B.CHEMICALS - Comparison Results

DIVIS LABORATORIES    Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES J.B.CHEMICALS DIVIS LABORATORIES/
J.B.CHEMICALS
 
P/E (TTM) x 18.3 14.0 130.8% View Chart
P/BV x 4.0 2.2 179.0% View Chart
Dividend Yield % 1.6 0.2 892.1%  

Financials

 DIVIS LABORATORIES   J.B.CHEMICALS
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-16
J.B.CHEMICALS
Mar-16
DIVIS LABORATORIES/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs2,484318 780.8%   
Low Rs918200 460.2%   
Sales per share (Unadj.) Rs142.3148.0 96.1%  
Earnings per share (Unadj.) Rs41.919.1 219.5%  
Cash flow per share (Unadj.) Rs46.323.9 193.5%  
Dividends per share (Unadj.) Rs10.000.50 2,000.0%  
Dividend yield (eoy) %0.60.2 304.3%  
Book value per share (Unadj.) Rs161.5128.9 125.3%  
Shares outstanding (eoy) m265.4784.82 313.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x12.01.7 683.7%   
Avg P/E ratio x40.613.6 299.5%  
P/CF ratio (eoy) x36.710.8 339.7%  
Price / Book Value ratio x10.52.0 524.7%  
Dividend payout %23.92.6 911.3%   
Avg Mkt Cap Rs m451,52521,951 2,056.9%   
No. of employees `0003.72.7 135.6%   
Total wages/salary Rs m3,6491,841 198.2%   
Avg. sales/employee Rs Th10,184.44,590.9 221.8%   
Avg. wages/employee Rs Th984.1673.4 146.1%   
Avg. net profit/employee Rs Th2,998.5592.1 506.4%   
INCOME DATA
Net Sales Rs m37,76412,551 300.9%  
Other income Rs m848542 156.6%   
Total revenues Rs m38,61213,093 294.9%   
Gross profit Rs m14,1382,055 688.1%  
Depreciation Rs m1,182412 286.6%   
Interest Rs m2396 24.2%   
Profit before tax Rs m13,7812,088 659.9%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,662469 567.6%   
Profit after tax Rs m11,1191,619 686.9%  
Gross profit margin %37.416.4 228.7%  
Effective tax rate %19.322.5 86.0%   
Net profit margin %29.412.9 228.3%  
BALANCE SHEET DATA
Current assets Rs m30,9477,778 397.9%   
Current liabilities Rs m5,1954,358 119.2%   
Net working cap to sales %68.227.2 250.3%  
Current ratio x6.01.8 333.8%  
Inventory Days Days11755 213.6%  
Debtors Days Days8580 106.4%  
Net fixed assets Rs m17,0275,713 298.1%   
Share capital Rs m531170 313.0%   
"Free" reserves Rs m42,34110,547 401.5%   
Net worth Rs m42,87710,937 392.0%   
Long term debt Rs m50-   
Total assets Rs m49,68415,574 319.0%  
Interest coverage x595.022.8 2,607.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.8 94.3%   
Return on assets %22.411.0 203.7%  
Return on equity %25.914.8 175.2%  
Return on capital %32.220.0 161.2%  
Exports to sales %85.348.7 175.0%   
Imports to sales %22.97.1 323.7%   
Exports (fob) Rs m32,1986,115 526.5%   
Imports (cif) Rs m8,654889 973.8%   
Fx inflow Rs m32,2706,169 523.1%   
Fx outflow Rs m8,7751,285 682.8%   
Net fx Rs m23,4964,884 481.1%   
CASH FLOW
From Operations Rs m10,3791,397 743.1%  
From Investments Rs m-4,135-320 1,290.9%  
From Financial Activity Rs m-6,241-1,196 521.9%  
Net Cashflow Rs m3-102 -3.2%  

Share Holding

Indian Promoters % 52.0 55.4 93.9%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 11.8 3.4 348.1%  
FIIs % 19.0 3.9 487.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 37.0 46.5%  
Shareholders   31,796 30,437 104.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   FRESENIUS KABI ONCO.  ELDER PHARMA  SUVEN LIFE  ALEMBIC PHARMA  AUROBINDO PHARMA  

Compare DIVIS LABORATORIES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Aug 23, 2017 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS